Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9977 - 9984 of 11442 results
Massachusetts SJC Rules on Fiduciary Duties Owed to and By Shareholder-Employee in Closely Held Corporation
April 1, 2014| Blog| Viewpoint
Privacy Monday - March 31, 2014 OPENING DAY!
March 31, 2014| Blog| Viewpoint
Five Key Decisions for ACOs Looking to Participate in the 2015 MSSP
March 28, 2014| Blog| Viewpoint
Amazon Prime Time – Should Employees Be Paid to Wait in Security Lines? Supreme Court to Decide.
March 28, 2014| Blog| Viewpoint
Final ACA Requirements and Penalties – And What You Should Be Doing
March 28, 2014| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Update on March 24, 2014
March 27, 2014| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.